Estadístiques de Acquired resistance to the anti-EFGR monoclonal antibody cetuximab in colorectal cancer
Visites totals
| views | |
|---|---|
| Acquired resistance to the anti-EFGR monoclonal antibody cetuximab in colorectal cancer | 27 |
Visites totals per mes
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
Vistes principals per país
| views | |
|---|---|
| United States | 17 |
| Australia | 2 |
| China | 1 |
| Spain | 1 |
| United Kingdom | 1 |
| Ireland | 1 |
| Iran | 1 |
| Mexico | 1 |
| Peru | 1 |
| Venezuela | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Mountain View | 7 |
| San Diego | 2 |
| Caracas | 1 |
| Glasgow | 1 |
| Lima | 1 |
| Madrid | 1 |
| Menlo Park | 1 |
| Mexicali | 1 |
| Seattle | 1 |
| Tustin | 1 |